Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes.

Molecular and Cellular Biology
E J FirpoJ M Roberts

Abstract

Peripheral blood T lymphocytes require two sequential mitogenic signals to reenter the cell cycle from their natural, quiescent state. One signal is provided by stimulation of the T-cell antigen receptor, and this induces the synthesis of both cyclins and cyclin-dependent kinases (CDKs) that are necessary for progression through G1. Antigen receptor stimulation alone, however, is insufficient to promote activation of G1 cyclin-Cdk2 complexes. This is because quiescent lymphocytes contain an inhibitor of Cdk2 that binds directly to this kinase and prevents its activation by cyclins. The second mitogenic signal, which can be provided by the cytokine interleukin 2, leads to inactivation of this inhibitor, thereby allowing Cdk2 activation and progression into S phase. Enrichment of the Cdk2 inhibitor from G1 lymphocytes by cyclin-CDK affinity chromatography indicates that it may be p27Kip1. These observations show how sequentially acting mitogenic signals can combine to promote activation of cell cycle proteins and thereby cause cell proliferation to start. CDK inhibitors have been shown previously to be induced by signals that negatively regulate cell proliferation. Our new observations show that similar proteins are down-regulate...Continue Reading

References

Jan 1, 1977·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·F TraganosM R Melamed
Nov 1, 1977·The Journal of Cell Biology·B J Reid, L H Hartwell
Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·S J ElledgeJ W Harper
Apr 1, 1992·Molecular Biology of the Cell·R L MarraccinoJ M Roberts
Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·K A WonM Z Gilman
Jan 1, 1992·Molecular Biology of the Cell·M J SolomonM W Kirschner
Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J RosenblattD O Morgan
May 1, 1992·Molecular Biology of the Cell·D DesaiD O Morgan
Aug 9, 1991·Cell·R Li, A W Murray
Dec 1, 1991·Genetics·L H Hartwell
May 17, 1991·Cell·Y XiongD Beach
Jun 15, 1990·Science·R H Schwartz
Nov 30, 1990·Cell·M J SolomonM W Kirschner
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S I Reed, C Wittenberg
Apr 1, 1990·Current Opinion in Cell Biology·A Zetterberg
Nov 3, 1989·Science·A B Pardee
Nov 3, 1989·Science·L H Hartwell, T A Weinert
Jan 1, 1987·Advances in Immunology·A Weiss, J B Imboden
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J C ReedR G Hoover

❮ Previous
Next ❯

Citations

Aug 17, 2006·Critical Reviews in Biochemistry and Molecular Biology·Annelies De Clercq, Dirk Inzé
Jun 15, 1997·European Journal of Biochemistry·S Herwig, M Strauss
Sep 7, 1995·Annals of the New York Academy of Sciences·J F ModianoE W Gelfand
Sep 1, 1996·European Journal of Biochemistry·A Udvardy
Jan 25, 2002·Journal of Cellular Physiology·Thomas Oelgeschläger
Oct 25, 2011·Molecular Aspects of Medicine·Dayong WuSimin Nikbin Meydani
Jun 23, 2009·Virus Research·Margaret E McLaughlin-Drubin, Karl Münger
Nov 16, 2004·Veterinary Immunology and Immunopathology·M Julia B F FlaminioDouglas F Antczak
Nov 25, 1997·Surgery·J A EhrenfriedB M Evers
Dec 2, 2005·Life Sciences·Kathleen M GilbertE Kim Fifer
Sep 5, 1998·Immunity·J J BirdS L Reiner
Nov 15, 2008·Virology·Margaret E McLaughlin-Drubin, Karl Münger
Jul 19, 2005·Cancer Cell·Keith R LoebJames M Roberts
Jan 27, 2015·European Journal of Pharmacology·Xinli NiuJunpeng Wang
May 18, 2001·Blood Cells, Molecules & Diseases·J GonzalezM B Prystowsky
Feb 23, 1999·The American Journal of Pathology·R V LloydB W Scheithauer
Jan 1, 1996·Annual Review of Immunology·R T Abraham, G J Wiederrecht
Jan 11, 2002·European Journal of Biochemistry·Sven EricksonDan Grandér
Aug 18, 2016·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Dayong Wu
Dec 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Xiangao HuangSelina Chen-Kiang
May 30, 2002·Science's STKE : Signal Transduction Knowledge Environment·Nancy Olashaw, W J Pledger
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y LiR Benezra
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·B L KellyJ M Roberts
Nov 18, 1994·Cell·C J Sherr
Oct 12, 2001·Journal of Cellular Biochemistry·B YaroslavskiyR A Steinman
Sep 1, 1996·Journal of Cellular Physiology·M J RavitzC E Wenner
Dec 19, 2003·Breast Cancer Research : BCR·Angel Alkarain, Joyce Slingerland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.